logo
919-206-7900
Polarean Imaging plc.'s technology is for research use only

Corporate News

Director Dealing

22 January 2020

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that yesterday it was notified that Dr Jonathan Allis, a Non-Executive Director of the Company, purchased 337,574 Ordinary Shares of £0.00037 ("Ordinary Shares") at an average price of 29.6 pence per share on 20 January 2020.

Following this transaction, Dr Allis now holds a beneficial interest in 1,877,574 Ordinary Shares, representing approximately 1.64 per cent. of the Company's issued share capital.

 

Enquiries:

Polarean Imaging plc www.polarean.com/www.polarean-ir.com
Richard Hullihen, Chief Executive Officer Via Walbrook PR
Richard Morgan, Chairman
SP Angel Corporate Finance LLP Tel: +44 (0)20 3470 0470
David Hignell / Soltan Tagiev (Corporate Finance)
Vadim Alexandre / Rob Rees (Corporate Broking)

Walbrook PR Tel: +44 (0)20 7933 8780 or[email protected]
Anna Dunphy / Paul McManus Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name: Dr Jonathan Allis
2. Reason for the notification
a) Position/status: Non-Executive Director
b) Initial notification/Amendment: Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name: Polarean Imaging Plc
b) LEI: 213800DGR2BHXJ36OL37
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument:

Identification code:
Ordinary shares of £0.00037

GB00BF3DT583
b) Nature of the transaction: Purchase of shares
c) Price(s) and volume(s):
Price(s) Volume(s)
29.9 pence 33,444
29.9 pence 33,444
29.9 pence 33,444
29.5 pence 33,898
29.5 pence 67,796
29.5 pence 50,847
29.5 pence 50,803
29.5 pence 33,898
d) Aggregated information:

Aggregated volume:

Price:
Price(s) Volume(s)
29.6 pence 337,574
e) Date of the transactions: 20 January 2020
f) Place of the transactions: AIM, London Stock Exchange